Vision Path, Inc.
Also known as: Hubble Contacts.
The FTC alleged that Hubble failed to obtain and verify contact lens prescriptions and substituted its own lenses for those prescribed, and did not disclose that many reviews were written by compensated reviewers including one of its own executives.
Resolved. Refunded, settled, ceased operating, or the claim did not hold up. Kept for the record.
Identity
Published so you can confirm this entry refers to the party you are checking, and not to somebody who shares a name.
- Registrations
- United States v. Vision Path, Inc., d/b/a Hubble Contacts (FTC case 182-3028, settled January 2022)
- Locations
- New York City, New York
- Jurisdictions
- United States (federal)
Two separate problems
Vision Path, the New York company selling direct-to-consumer Hubble contact lenses, agreed in January 2022 to pay penalties and redress totaling $3.5 million.
The first set of charges concerns the Contact Lens Rule. The FTC alleged the company failed to obtain prescriptions, failed to properly verify prescription information, and substituted Hubble lenses for the lenses actually prescribed. A contact lens is a regulated medical device fitted to a specific eye, which is why that rule exists.
The second concerns the reviews. The FTC alleged the company violated the FTC Act by failing to disclose that many reviews of Hubble lenses were not written by unbiased consumers. They were written by reviewers who were compensated, and in at least one instance by one of the company’s own executives.
What is not established
The only supplied document is a short case page summary. It does not give the number of consumers affected, the period covered, the split between penalties and redress, or the specific reviews at issue, so none of that appears here. A settlement resolves allegations without any admission or finding of wrongdoing.
Sources
Every claim above rests on one of these. Open them and check.
- Enforcement action September 1, 2022
Right of reply
If you are named here and something is wrong, dispute this entry. There is no charge, the route never expires, and your response is published unedited.
Other marketing & creative entries
See all marketing & creative entries, or browse the full record.
First recorded September 1, 2022 · Last updated September 1, 2022